Correlation Between Leap Therapeutics and Lexicon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Leap Therapeutics and Lexicon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leap Therapeutics and Lexicon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Leap Therapeutics and Lexicon Pharmaceuticals, you can compare the effects of market volatilities on Leap Therapeutics and Lexicon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leap Therapeutics with a short position of Lexicon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leap Therapeutics and Lexicon Pharmaceuticals.
Diversification Opportunities for Leap Therapeutics and Lexicon Pharmaceuticals
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Leap and Lexicon is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and Lexicon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexicon Pharmaceuticals and Leap Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leap Therapeutics are associated (or correlated) with Lexicon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexicon Pharmaceuticals has no effect on the direction of Leap Therapeutics i.e., Leap Therapeutics and Lexicon Pharmaceuticals go up and down completely randomly.
Pair Corralation between Leap Therapeutics and Lexicon Pharmaceuticals
Given the investment horizon of 90 days Leap Therapeutics is expected to generate 0.5 times more return on investment than Lexicon Pharmaceuticals. However, Leap Therapeutics is 2.0 times less risky than Lexicon Pharmaceuticals. It trades about -0.31 of its potential returns per unit of risk. Lexicon Pharmaceuticals is currently generating about -0.39 per unit of risk. If you would invest 417.00 in Leap Therapeutics on August 31, 2024 and sell it today you would lose (122.00) from holding Leap Therapeutics or give up 29.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Leap Therapeutics vs. Lexicon Pharmaceuticals
Performance |
| Timeline |
| Leap Therapeutics |
| Lexicon Pharmaceuticals |
Leap Therapeutics and Lexicon Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Leap Therapeutics and Lexicon Pharmaceuticals
The main advantage of trading using opposite Leap Therapeutics and Lexicon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leap Therapeutics position performs unexpectedly, Lexicon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexicon Pharmaceuticals will offset losses from the drop in Lexicon Pharmaceuticals' long position.| Leap Therapeutics vs. X4 Pharmaceuticals | Leap Therapeutics vs. Terns Pharmaceuticals | Leap Therapeutics vs. Day One Biopharmaceuticals | Leap Therapeutics vs. PDS Biotechnology Corp |
| Lexicon Pharmaceuticals vs. BioLineRx | Lexicon Pharmaceuticals vs. Ardelyx | Lexicon Pharmaceuticals vs. Seres Therapeutics | Lexicon Pharmaceuticals vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |